Alterity Therapeutics

1 follower

Alterity is developing first-in-class therapies to treat neurodegenerative disease.

Industries

Employees

11-50

Links


Org chart

David Stamler
Chief Executive Officer
Collapse
Jim Kerr
Vice President, CMC
Cynthia Wong
Vice President Clinical Operations
Margaret Bradbury
VP, Nonclinical Development
Tara Speranza
Head of Investor Relations and Communications

Board & advisors

Geoffrey Paul Kempler
Non-Executive Chairman
Lawrence Gozlan
Non-Executive Director
Peter Marks
Non-Executive Director
Brian Meltzer
Non-Executive Director